SinghalAB. Reversible cerebral vasoconstriction syndrome: a review of pathogenesis, clinical presentation, and treatment. Int J Stroke. 2023; 18: 1151–1160.
2.
MarkusHSLeviCKingAMadiganJNorrisJ; Cervical Artery Dissection in Stroke Study (CADISS) Investigators. Antiplatelet therapy vs anticoagulation therapy in cervical artery dissection: the Cervical Artery Dissection in Stroke Study (CADISS) randomized clinical trial final results. JAMA Neurol2019; 76: 657–664.
3.
Mayer-SuessLDejakumBRatzingerGGizewskiERKiechlSKnoflachM. Clinical characteristics and outcome in expansive compared with steno-occlusive mural hematoma in spontaneous cervical artery dissection. Int J Stroke. 2023; 18: 1186–1192.
4.
LounsburyENiznickNMallickR, et al. Recurrence of cervical artery dissection: a systematic review and meta-analysis. Int J Stroke. Epub ahead of print 21September2023. DOI: 10.1177/17474930231201434.
5.
OldgrenJÅsbergSHijaziZ, et al. Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study. Circulation2022; 146: 1056–1066.
6.
FischerUKogaMStrbianD, et al. Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med2023; 388: 2411–2421.
7.
KingBTLawrencePDMillingTJWarachSJ. Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a pragmatic, response–adaptive, prospective randomized clinical trial. Int J Stroke2019; 14: 977–982.
8.
BestJGArramLAhmedN, et al. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke2022; 17: 583–589.
9.
GrosseGMHüsingAStangA, et al. Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: the PRODAST study. Int J Stroke. 2023; 18: 1169–1177.
10.
WilsonDAmblerGShakeshaftC, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol2018; 17: 539–547.
11.
NannoniSOhlmeierLBrownRB, et al. Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease. Int J Stroke2022; 17: 415–424.
12.
MoutzouriEGlutzMAbolhassaniN, et al. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: a prospective cohort study. Int J Stroke. 2023; 18: 1219–1227.
13.
ThorénMEscudero-MartínezIAnderssonT, et al. Reperfusion by endovascular thrombectomy and early cerebral edema in anterior circulation stroke: results from the SITS-International Stroke Thrombectomy Registry. Int J Stroke. 2023; 18: 1193–1201.
14.
CappellariMPracucciGSaiaV, et al. Predictors for hemorrhagic transformation and cerebral edema in stroke patients with first-pass complete recanalization. Int J Stroke. 2023; 18: 1238–1246.
15.
AdemolaAThabaneLAdekanyeJ, et al. The credibility of subgroup analyses reported in stroke trials is low: a systematic review. Int J Stroke. 2023; 18: 1161–1168.
